Published in Neurology on April 22, 1999
Association between essential tremor and other neurodegenerative diseases: what is the epidemiological evidence? Neuroepidemiology (2011) 1.70
Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes. BMC Neurol (2007) 1.05
Neuroimaging essentials in essential tremor: a systematic review. Neuroimage Clin (2014) 0.93
Combined measures of movement and force variability distinguish Parkinson's disease from essential tremor. Clin Neurophysiol (2011) 0.90
Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT. Eur J Nucl Med Mol Imaging (2008) 0.81
[(123)I]-FP-CIT SPECT and olfaction test in patients with combined postural and rest tremor. J Neural Transm (Vienna) (2008) 0.81
Use of a single [123I]-FP-CIT SPECT to predict the severity of clinical symptoms of Parkinson disease. Neurol Sci (2009) 0.80
What is essential tremor? Curr Neurol Neurosci Rep (2013) 0.79
Dopamine transporter imaging in essential tremor with and without parkinsonian features. J Neural Transm (Vienna) (2015) 0.77
Benign tremulous Parkinsonism: a unique entity or another facet of Parkinson's disease? Transl Neurodegener (2016) 0.76
Dystonia and Tremor: The Clinical Syndromes with Isolated Tremor. Tremor Other Hyperkinet Mov (N Y) (2016) 0.76
How to tackle tremor - systematic review of the literature and diagnostic work-up. Front Neurol (2012) 0.75
Positron emission tomography in the differential diagnosis of parkinsonism. J Mov Disord (2009) 0.75
Control of circadian rhythms and photoperiodic flowering by the Arabidopsis GIGANTEA gene. Science (1999) 4.42
Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness. N Engl J Med (1998) 4.34
Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. Neurology (2009) 3.49
Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem (2000) 3.45
Tn10 transposase acts preferentially on nearby transposon ends in vivo. Cell (1983) 3.23
An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry (2001) 3.05
Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest (1999) 2.94
Imaging of dopamine transporters in humans with technetium-99m TRODAT-1. Eur J Nucl Med (1996) 2.91
The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry (1998) 2.88
Nutritional deficit as a negative prognostic factor in patients with miliary tuberculosis. Eur Respir J (2008) 2.84
EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol (2011) 2.63
PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment. Neurology (2007) 2.63
Movement disorders in multiple sclerosis. Mov Disord (1995) 2.53
Neuroimaging features of neurodegeneration with brain iron accumulation. AJNR Am J Neuroradiol (2011) 2.30
Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls. Neurology (2009) 2.27
Impact of resistance to first-line and injectable drugs on treatment outcomes in MDR-TB. Eur Respir J (2009) 2.15
Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psychiatry (2008) 2.12
A prospective randomised comparison of two insertion methods for i-gel placement in anaesthetised paralysed patients: standard vs. rotational technique. Anaesthesia (2014) 2.11
Stroke mechanism in patients with non-valvular atrial fibrillation according to the CHADS2 and CHA2 DS2 -VASc scores. Eur J Neurol (2011) 2.09
Micrographia after thalamo-mesencephalic infarction: evidence of striatal dopaminergic hypofunction. Neurology (1998) 2.07
Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder. Brain (1995) 2.06
Comparison of techniques for double-lumen endobronchial intubation: 90° or 180° rotation during advancement through the glottis. Br J Anaesth (2013) 2.03
Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study. Neurogastroenterol Motil (2012) 2.03
Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis. Ann Oncol (2013) 2.02
Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma. AJNR Am J Neuroradiol (2011) 2.00
Economic burden of smoking in Korea. Tob Control (2003) 1.99
Autosomal dominant frontal epilepsy misdiagnosed as sleep disorder. Lancet (1994) 1.95
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology (2001) 1.95
Current status of the Maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg (2000) 1.94
Surgical techniques and innovations in living related liver transplantation. Ann Surg (1993) 1.88
Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Res Clin Pract (1999) 1.87
The absorption of orally supplied beta-alanine and its effect on muscle carnosine synthesis in human vastus lateralis. Amino Acids (2006) 1.86
Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease. Neurology (2006) 1.85
Biliary papillomatosis: clinical, cholangiographic and cholangioscopic findings. Endoscopy (1998) 1.85
Patterns of progression in patients with recurrent glioblastoma treated with bevacizumab. Neurology (2011) 1.85
Abnormal sensorimotor plasticity in organic but not in psychogenic dystonia. Brain (2009) 1.82
Aspirin use and bleeding risk after endoscopic submucosal dissection in patients with gastric neoplasms. Endoscopy (2012) 1.81
Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation. Neurology (2005) 1.77
Severe tongue protrusion dystonia: clinical syndromes and possible treatment. Neurology (2006) 1.72
The inflammation hypothesis of aging: molecular modulation by calorie restriction. Ann N Y Acad Sci (2001) 1.70
Osteonecrosis of the jaw induced by oral administration of bisphosphonates in Asian population: five cases. Osteoporos Int (2009) 1.70
Influence of beta-alanine supplementation on skeletal muscle carnosine concentrations and high intensity cycling capacity. Amino Acids (2006) 1.69
A new strategy to predict the neoplastic polyps of the gallbladder based on a scoring system using EUS. Gastrointest Endosc (2000) 1.69
The natural history of tardive dystonia. A long-term follow-up study of 107 cases. Brain (1998) 1.65
Mechanisms of fenretinide-induced apoptosis. Apoptosis (2006) 1.64
BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease. J Neurol Neurosurg Psychiatry (2008) 1.63
Beyond prejudice as simple antipathy: hostile and benevolent sexism across cultures. J Pers Soc Psychol (2000) 1.62
Actin-binding cellular proteins inside human immunodeficiency virus type 1. Virology (2000) 1.62
Montelukast improves regional air-trapping due to small airways obstruction in asthma. Eur Respir J (2006) 1.61
Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica. Mult Scler (2009) 1.58
Comparison of chest digital tomosynthesis and chest radiography for detection of asbestos-related pleuropulmonary disease. Clin Radiol (2012) 1.55
Validity of clinical diagnosis in dementia: a prospective clinicopathological study. J Neurol Neurosurg Psychiatry (1985) 1.54
Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J Cell Biochem (1999) 1.54
IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling. Cell Death Differ (2009) 1.53
The role of DAT-SPECT in movement disorders. J Neurol Neurosurg Psychiatry (2010) 1.53
The blink reflex recovery cycle differs between essential and presumed psychogenic blepharospasm. Neurology (2011) 1.53
Vein involvement during pancreaticoduodenectomy: is there a need for redefinition of "borderline resectable disease"? J Gastrointest Surg (2013) 1.52
Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer. Br J Cancer (2013) 1.50
Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings. Radiology (2001) 1.50
Atypical and typical cranial dystonia following dental procedures. Mov Disord (1999) 1.49
In vivo mapping of amyloid toxicity in Alzheimer disease. Neurology (2009) 1.47
Primary stenting for acute myocardial infarction via the transradial approach: a safe and useful alternative to the transfemoral approach. J Invasive Cardiol (2000) 1.47
Prostate-specific antigen and prostate volume in Korean men with spinal cord injury: a case-control study. Spinal Cord (2007) 1.46
Difference in direct charge-parity violation between charged and neutral B meson decays. Nature (2008) 1.46
Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes (2000) 1.46
Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients. J Neurol Neurosurg Psychiatry (2009) 1.46
Oleoyl-CoA is the major de novo product of stearoyl-CoA desaturase 1 gene isoform and substrate for the biosynthesis of the Harderian gland 1-alkyl-2,3-diacylglycerol. J Biol Chem (2001) 1.45
Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain. J Biol Chem (1996) 1.45
Intracardiac thrombus formation induced by carbon monoxide poisoning. Hum Exp Toxicol (2013) 1.45
The Department of Neurosurgery at Seoul National University: past, present, and future. Neurosurgery (2001) 1.44
Studies in thoracic aortic graft infections: the development of a porcine model and a comparison of collagen-impregnated dacron grafts and cryopreserved allografts. J Thorac Cardiovasc Surg (1999) 1.43
Change of insulin sensitivity in hepatitis C patients with normal insulin sensitivity: a 5-year prospective follow-up study variation of insulin sensitivity in HCV patients. Intern Med J (2009) 1.43
Copper-binding compounds from Methylosinus trichosporium OB3b. J Bacteriol (1998) 1.43
Transduction of retrovirus-mediated NeoR gene into CD34+ cells purified from granulocyte colony-stimulating factor (G-CSF)-mobilized infant and cord blood. Exp Hematol (1997) 1.43
All in the blink of an eye: new insight into cerebellar and brainstem function in DYT1 and DYT6 dystonia. Eur J Neurol (2014) 1.42
Risk factors for recurrence of primary bile duct stones after endoscopic biliary sphincterotomy. Gastrointest Endosc (2001) 1.42
Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease. Acta Neuropathol (2000) 1.41
Essential tremor: an overdiagnosed condition? J Neurol (2000) 1.40
HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry. Histopathology (2006) 1.39
PET amyloid ligand [11C]PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairment. Dement Geriatr Cogn Disord (2008) 1.39
Pseudobasophilia as an erroneous white blood cell differential count with a discrepancy between automated cell counters: report of two cases. Clin Lab Haematol (2004) 1.39
Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo. Am J Psychiatry (1998) 1.39
Kinetic roughening of ion-sputtered Pd(001) surface: beyond the Kuramoto-Sivashinsky model. Phys Rev Lett (2004) 1.38
Steroid receptor coactivator-1 coactivates activating protein-1-mediated transactivations through interaction with the c-Jun and c-Fos subunits. J Biol Chem (1998) 1.37
Role of the dopaminergic system in chronic pain -- a fluorodopa-PET study. Pain (2001) 1.37
The mouse Dlx-2 (Tes-1) gene is expressed in spatially restricted domains of the forebrain, face and limbs in midgestation mouse embryos. Mech Dev (1993) 1.35
An Internet-based surveillance system for tuberculosis in Korea. Int J Tuberc Lung Dis (2006) 1.35
Somatic hypermutation in the absence of DNA-dependent protein kinase catalytic subunit (DNA-PK(cs)) or recombination-activating gene (RAG)1 activity. J Exp Med (2000) 1.34
PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease. Brain (2008) 1.34
Clinical guidelines for the management of craniofacial fibrous dysplasia. Orphanet J Rare Dis (2012) 1.33
Randomized clinical trial of robot-assisted versus standard laparoscopic right colectomy. Br J Surg (2012) 1.33
Spinal intradural extramedullary capillary hemangioma: MR imaging findings. AJNR Am J Neuroradiol (2001) 1.33
Cyclophilin a binds to peroxiredoxins and activates its peroxidase activity. J Biol Chem (2001) 1.32
Tumor suppressor p16INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4. Mol Cell (1998) 1.32
Patient characteristics, clinical, endoscopic, and histologic findings in adult eosinophilic esophagitis: a case series and systematic review of the medical literature. Dis Esophagus (2007) 1.32
The cerebellum in dystonia - help or hindrance? Clin Neurophysiol (2011) 1.31